Creo Medical Group (LON:CREO) Stock Price Up 2.6% – What’s Next?

Shares of Creo Medical Group PLC (LON:CREO) traded up 2.6% during mid-day trading on Tuesday . The stock traded as high as GBX 19.50 ($0.24) and last traded at GBX 19.50 ($0.24). 149,612 shares changed hands during trading, a decline of 75% from the average session volume of 598,117 shares. The stock had previously closed at GBX 19 ($0.24).

Creo Medical Group Stock Up 2.6 %

The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The company has a market cap of £70.55 million, a P/E ratio of -325.00 and a beta of 0.86. The business’s 50 day moving average is GBX 18.12 and its 200 day moving average is GBX 22.03.

Insider Buying and Selling at Creo Medical Group

In other news, insider Kevin Crofton purchased 1,179,000 shares of the company’s stock in a transaction on Friday, December 13th. The shares were acquired at an average price of GBX 17 ($0.21) per share, for a total transaction of £200,430 ($249,570.41). Also, insider Richard John Rees acquired 4,712 shares of Creo Medical Group stock in a transaction dated Thursday, January 16th. The stock was purchased at an average price of GBX 19 ($0.24) per share, with a total value of £895.28 ($1,114.78). Over the last ninety days, insiders acquired 1,188,424 shares of company stock worth $20,222,056. 22.43% of the stock is owned by insiders.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.